Dr. Lindsay Sun, M.D., M.S.
Dr. Lindsay Sun, M.D., M.S.

Dr. Sun joined Beckman Coulter in 2009 and has focused on bringing clinical insights into product development for Immunoassay projects, currently working on biomarkers in heart failure, blood virus, and Reproductive Endocrinology. Her expertise in statistics and knowledge of medical needs ensure the quality of research study design and analysis.

Dr. Sun currently represents Beckman Coulter at the IFCC Committee on Clinical Applications of Cardiac Biomarkers and is an associate member of Early Detection Research Network (EDRN) under NIH for biomarker discovery and validation in early cancer detection.

Dr. Sun received her M.D. from a physician-scientist dual-degree program at Shanghai Medical University, China. She was an Endocrinologist in Shanghai and received her M.S. degree in Statistics from North Carolina State University.

The Impact of IL-6 on Severe COVID-19 Patients

The Impact of IL-6 on Severe COVID-19 Patients

Elevations in IL-6 levels may be an important mediator when severe systemic inflammatory responses occur in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Learn more about the connection between IL-6, Cytokine Storm Syndrome and COVID-19 in this blog.
Using Anti-Müllerian Hormone to Determine Ovarian Reserve

Using Anti-Müllerian Hormone to Determine Ovarian Reserve

Globally, infertility impacts millions of couples. For women, one challenge can be a lack of ovulation. Learn how AMH testing is used to determine egg reserve and help couples achieve their dream of parenthood.
How High Sensitivity Testing Has Revolutionized Cardiac Care

How High Sensitivity Testing Has Revolutionized Cardiac Care

Each year, millions of patients visit the Emergency Department with chest pain. Incorporating high-sensitivity troponin testing is essential for detecting cardiac damage.
The evolution of high-sensitivity HIV diagnostic testing

The evolution of high-sensitivity HIV diagnostic testing

High-sensitivity diagnostic immunoassay testing is vital for meeting the increased HIV testing demands and enabling earlier treatment, which may curb viral transmissions by detecting infections sooner.